• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Mark Fendrick Suggests Additional VBID Elements to Be Adopted in Health Policy

Video

Congress should build on the value-based insurance design (VBID) elements included in the Inflation Reduction Act to further alleviate the burden of health care costs on Americans, said A. Mark Fendrick, MD, co–editor in chief of The American Journal of Managed Care® and director of the V-BID Center at the University of Michigan.

Congress should build on the value-based insurance design (VBID) elements included in the Inflation Reduction Act (IRA) to further alleviate the burden of health care costs on Americans, said A. Mark Fendrick, MD, co–editor in chief of The American Journal of Managed Care® and director of the V-BID Center at the University of Michigan.

Transcript

What additional VBID elements would you like to see the government adopt?

Well, while we were very pleased to see the insulin out-of-pocket cap of $35
implemented for Medicare, we fell just a few votes short of having this as a national policy for all plans. So it is our hope that Congress will revisit the commercial plan out-of-pocket cap and then we could see insulin out-of-pocket cost no longer be such a burden for everyone who is insured.

Another area that we’re working on is to expand the Internal Revenue Service list of chronic disease services that could be covered on a predeductible basis. We were happy to see the codification of predeductible coverage for insulin in the IRA. We would like to see this to include many other highly valuable evidence-based services used to manage and prevent the complications of chronic conditions that are not included in the 14 services that already have this allowable predeductible coverage.

Related Videos
Debra Boyer, MD, MHPE, ATSF.
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Plasminogen is vital in the body's coagulation process and breaking down clots | image credit: peterschreiber.media - stock.adobe.com
ISPOR 2024 Recap
Chris Pagnani, MD, PC
Screenshot of Stephen Freedland, MD, during a video interview
Phaedra Corso, PhD, associate vice president for research at Indiana University
Julie Patterson, PharmD, PhD
William Padula, PhD, MSc, MS, assistant professor of pharmaceutical and health economics, University of California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Michael Morse, MD, Duke Cancer Center
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.